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Congenital malaria is commonly defined as the presence of Plasmodium spp. parasites in the peripheral blood during the first 7 days of life where transmission occurs 
transplacentally [1]. Parasites are identified in the peripheral 
blood of neonate and not the umbilical cord blood or placenta [1]. 
Although the use of umbilical cord blood has been proposed as an 
alternative to peripheral blood, it does not represent active infection. 
Falade et al. noted spontaneous clearance of parasitemia in 62% of 
neonates born, before day 2 of birth, and maternal and placental 
parasitemia were the most important risk factors for patent neonatal 
parasitemia [2]. The incidence of congenital malaria depends on 
various factors such as geographical area, time period of reporting, 
and clinical definition [1]. Incidence of congenital malaria has been 
reported to be in the range between 0.3% and 30% both in endemic 
and non-endemic areas [3-8]. Most of these studies were conducted 
in areas with Plasmodium falciparum as the predominant species, 
whereas in India, it is Plasmodium vivax [4,9-15].
The rate of transmission of the parasite is low during pregnancy 
due to the placenta acting as a barrier to maternally infected red 
blood cells, passive immunity by maternal antibodies, and the 
protective role of fetal hemoglobin (Hb) [1]. Placental malaria is 
asymptomatic and silently causes fetal wasting. Among the firstborn, 
it can significantly affect the birth weight, the differences usually 
around 150–300 g [5]. Malaria during pregnancy is an unestablished 
risk factor for increased infant morbidity and mortality in endemic 
areas. Maternal malaria during pregnancy may cause serious anemia 
and adversely affect the placental circulation interfering with 
nutrition and oxygenation of the fetus. It is associated with abortion, 
stillborn, prematurity, fetal growth retardation, and neonatal deaths. 
Neonate can present with fever, irritability, feeding problems, 
hepatosplenomegaly, anemia, and jaundice [5].
CASE REPORT
A 1-month-old male baby was admitted to our institute with 
complaints of high-grade fever for 5 days and feeding difficulty 
for 1 day. The baby was born vaginally at term with birth weight 
2.3 kg. Postnatal period was uneventful. On examination, the baby 
was irritable but consolable, febrile with axillary temperature 
of 101°F. Systemic examination was unremarkable except for 
mild splenomegaly. Liver was palpable 1.5 cm below costal 
margin, normal in consistency, and texture. Spleen was palpable 
1 cm below costal margin and was firm in consistency. Pending 
investigation reports, the baby was started on intravenous (IV) 
fluids and empirical antibiotics (Inj. cefotaxime).
Investigations were done which showed Hb 12.0 g/dl, total 
lymphocyte count 8200/mm3, platelet count 0.28 lacs/mm3, and 
C-reactive protein 20.55 mg/dl. Peripheral smear showed the 
presence of schizonts of P. vivax, normocytic normochromic 
picture, and white blood cell showing left shift with increased 
immature forms (Fig. 1). Malaria parasite rapid test came out to 
be positive for the parasite.
Antenatal history of mother was reviewed and she was found 
to have a history of chills and rigors in her first trimester and was 
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smear positive for P. vivax. She was treated with Inj. artesunate in 
adequate dose (120 mg IV for three doses) over 2 days followed 
by a combination therapy of artemether and lumefantrine 
(80 mg/480 mg) twice daily for 3 days. Based on the history, 
clinical examination, and presentation of baby, the diagnosis of 
congenital malaria was made. The child was treated with Inj. 
artesunate (10 mg once daily for 7 days) and Inj. clindamycin 
(40 mg twice daily for 7 days). The child showed clinical 
improvement and repeated investigations after 48 h of therapy, 
showed a prompt increase in platelet counts (206,000/mm3) along 
with the clearance of malarial parasites in blood.
DISCUSSION
It is estimated that the incidence of congenital malaria is 0.3–
30%, as reported by Fischer [3]. Although malaria continues to be 
a major public health problem in India and pregnant women have 
been described as the vulnerable group, there have been very few 
epidemiological studies to determine disease burden in pregnancy 
and infants [4-6]. The pathophysiology of congenital malaria 
is due to maternal transfusion into the fetal circulation during 
pregnancy or at delivery or due to direct penetration of chorionic 
villi. The incidence of congenital malaria is low in pregnancy as 
the placenta acts as a barrier to the malarial parasites, the role 
of passive immunity by maternal antibodies, and due to the 
protective role of fetal Hb [5,6].
The symptoms of congenital malaria are usually delayed and 
literature describes the clinical symptom onset to be between 3 
and 6 weeks after birth [1]. Placental malaria does not always end 
in malarial infection of newborn but can lead to low birth weight 
of newborns, intrauterine growth restriction, preterm labor, and 
intrauterine fetal death.
In this case, mother was smear positive for P. vivax in her 
first trimester for which she was adequately treated. However, 
it failed to limit transmission to the newborn emphasizing the 
fact that congenital malaria should be kept in mind as differential 
diagnosis in newborn presenting with clinical features of sepsis 
even if mother has been adequately treated or if the infection is 
acquired in the first trimester.
CONCLUSION
Antimalarial therapy to pregnant mother might not always prevent 
transmission of malaria to newborn. Congenital malaria should be 
considered as a differential diagnosis in newborn presenting with 
clinical features of sepsis even if the infection is acquired in the 
first trimester and the mother has been adequately treated.
REFERENCES
1. Michaels MG, Sanchez P, Lin PL. Congenital toxoplasmosis, syphilis, 
malaria and tuberculosis. Malaria. In: Avery’s Disease of New Born. 10th ed., 
Ch. 38. New York: Elsevier; 2018. p. 538-45.
2. Falade C, Mokuolo O, Okafor H, Orogade A, Falade A, Adedoyin O, et al. 
Epidemiology of congenital malaria in Nigeria: A multi-centre study. Trop 
Med Int Health 2007;12:1279-87.
3. Fischer PR. Malaria and newborn. J Trop Pediatr 2003;49:132-4.
4. Singh J, Soni D, Mishra D, Singh HP, Bijesh S. Placental and neonatal 
outcome in maternal malaria. Indian Pediatr 2014;51:285-8.
5. Nosten F, McGready R, Simpson JA, Thwai KL, Balkan S, Cho T, et al. 
Effects of Plasmodium vivax malaria in pregnancy. Lancet 1999;354:546-9.
6. Singh N, Mehra RK, Srivastava N. Malaria during pregnancy and infancy, 
in an area of intense malaria transmission in central India. Ann Trop Med 
Parasitol 2001;95:19-29.
7. Akindele JA, Sowunmi A, Abohweyere AE. Congenital malaria in a 
hyperendemic area: A preliminary study. Ann Trop Paediatr 1993;13:273-6.
8. Ekanem AD, Anah MU, Udo JJ. The prevalence of congenital malaria among 
neonates with suspected sepsis in Calabar, Nigeria. Trop Doct 2008;38:73-6.
9. Sahoo S, Bandyopadhyay A. Congenital Plasmodium vivax malaria and 
intracranial hemorrhage. Indian J Pediatr 2014;81:959-60.
10. Gandhi A, Garg K, Wadhwa N. Neonatal Plasmodium vivax malaria: An 
overlooked entity. J Infect Dev Ctries 2011;5:489-92.
11. Chandelia S, Jain S, Dubey NK. Congenital Vivax malaria: Rare or 
underdiagnosed infection. Trop Doc 2013;43:161-3.
12. Valecha N, Bhatia S, Mehta S, Biswas S, Dash AP. Congenital malaria with 
atypical presentation: A case report from low transmission area in India. 
Malar J 2007;6:43.
13. Rai P, Majumdar K, Sharma S, Chauhan R, Chandra J. Congenital malaria 
in a neonate: Case report with a comprehensive review on differential 
diagnosis, treatment and prevention in Indian perspective. J Parasit Dis 
2015;39:345-8.
14. Mohan K, Maithani MM. Congenital malaria due to chloroquine-resistant 
Plasmodium vivax: A case report. J Trop Pediatr 2010;56:454-5.
15. Sankar J, Menon R, Kottarathara AJ. Congenital malaria-a case report from 
a non-endemic area. Trop Biomed 2010;27:326-9.
Figure 1: Peripheral smear of baby
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